WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011136927) 3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)-5-ARYL-1,2,4-OXADIAZOLE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/136927    International Application No.:    PCT/US2011/032267
Publication Date: 03.11.2011 International Filing Date: 13.04.2011
IPC:
C07D 413/10 (2006.01), A61K 31/4245 (2006.01), A61P 27/02 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive Irvine, California 92612 (US) (For All Designated States Except US).
TAKEUCHI, Janet A. [US/US]; (US) (For US Only).
CHOW, Ken [US/US]; (US) (For US Only).
LI, Ling [US/US]; (US) (For US Only)
Inventors: TAKEUCHI, Janet A.; (US).
CHOW, Ken; (US).
LI, Ling; (US)
Agent: ENE, Doina G.; Allergan, INC. 2525 Dupont Drive Irvine, California 92612 (US)
Priority Data:
61/328,395 27.04.2010 US
Title (EN) 3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)-5-ARYL-1,2,4-OXADIAZOLE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS
(FR) DÉRIVÉS DE 3-(4-((1H-IMIDAZOL-1-YL)MÉTHYL)PHÉNYL)-5-ARYL-1,2,4-OXADIAZOLE EN TANT QUE MODULATEURS DE RÉCEPTEURS DE SPHINGOSINE-1-PHOSPHATE
Abstract: front page image
(EN)Substituted 3 - (4 - ( ( 1H- imidazol - 1 -yl) methyl) phenyl) - 5 -phenyl- 1, 2, 4 -oxadiazole derivatives of formula I which are useful as sphingosine- 1 -phosphate modulators and useful for treating a wide variety of disorders associated with modulation of sphingosine- 1 -phosphate receptors.
(FR)La présente invention concerne des dérivés de 3‑(4‑((1H-imidazol‑1‑yl)méthyl)phényl)‑5‑phényl-1,2,4‑oxadiazole substitués de formule I qui sont utiles en tant que modulateurs de sphingosine-1‑phosphate et utiles pour traiter une large gamme de troubles associés à la modulation de récepteurs de sphingosine-1‑phosphate.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)